Total Payments
$1.5M
2024 Payments
$272,942
Companies
31
Transactions
3,022
Medicare Patients
10,871
Medicare Billing
$1.7M
Payment Breakdown by Category
Other$1.2M (80.7%)
Travel$142,265 (9.8%)
Consulting$91,925 (6.3%)
Food & Beverage$45,432 (3.1%)
Education$314.91 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.2M | 617 | 80.7% |
| Travel and Lodging | $142,265 | 972 | 9.8% |
| Consulting Fee | $91,925 | 34 | 6.3% |
| Food and Beverage | $45,432 | 1,381 | 3.1% |
| Education | $314.91 | 18 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $622,131 | 1,188 | $0 (2024) |
| ABBVIE INC. | $345,614 | 609 | $0 (2024) |
| UCB, Inc. | $152,467 | 365 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $114,988 | 238 | $0 (2024) |
| GlaxoSmithKline, LLC. | $97,523 | 143 | $0 (2024) |
| GENZYME CORPORATION | $79,231 | 174 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30,295 | 36 | $0 (2024) |
| PFIZER INC. | $3,312 | 27 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $2,058 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $1,164 | 72 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $272,942 | 529 | Amgen Inc. ($149,640) |
| 2023 | $207,529 | 397 | Amgen Inc. ($83,089) |
| 2022 | $214,729 | 411 | Amgen Inc. ($110,694) |
| 2021 | $156,667 | 339 | Amgen Inc. ($68,653) |
| 2020 | $144,214 | 225 | AbbVie Inc. ($40,971) |
| 2019 | $266,646 | 572 | Amgen Inc. ($98,430) |
| 2018 | $102,957 | 302 | Amgen Inc. ($38,122) |
| 2017 | $86,487 | 247 | Amgen Inc. ($41,738) |
All Payment Transactions
3,022 individual payment records from CMS Open Payments — Page 1 of 121
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: Immunology | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/22/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $53.60 | General |
| Category: Bone Health | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $154.10 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | Cash or cash equivalent | $15.30 | General |
| Category: Immunology | ||||||
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $72.93 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $481.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $154.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $96.91 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $95.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $70.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $50.92 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $19.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,265 | 6,380 | $757,309 | $206,849 |
| 2022 | 26 | 1,999 | 19,531 | $1.4M | $372,949 |
| 2021 | 30 | 3,278 | 42,413 | $1.8M | $630,622 |
| 2020 | 31 | 4,329 | 33,821 | $1.2M | $491,455 |
Total Patients
10,871
Total Services
102,145
Medicare Billing
$1.7M
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 46 | 4,320 | $254,760 | $79,417 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 347 | 504 | $143,640 | $47,500 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 158 | 302 | $120,800 | $41,559 | 34.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 33 | 210 | $92,610 | $10,455 | 11.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $29,700 | $9,275 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,294 | $2,631 | 31.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 61 | 61 | $20,110 | $2,400 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $5,535 | $1,894 | 34.2% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 32 | 32 | $6,624 | $1,624 | 24.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 43 | 49 | $10,143 | $1,398 | 13.8% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2023 | 23 | 23 | $3,910 | $1,285 | 32.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 68 | 129 | $8,643 | $1,271 | 14.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 72 | 145 | $2,755 | $1,211 | 43.9% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 11 | 11 | $15,490 | $1,008 | 6.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 67 | 134 | $6,298 | $979.66 | 15.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 85 | $12,835 | $851.68 | 6.6% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 54 | 115 | $5,750 | $558.06 | 9.7% |
| 72050 | X-ray of upper spine, 4-5 views | Office | 2023 | 12 | 12 | $2,464 | $497.87 | 20.2% |
| 77089 | Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | Office | 2023 | 14 | 14 | $1,893 | $405.72 | 21.4% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $1,521 | $340.31 | 22.4% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 53 | 114 | $3,534 | $288.32 | 8.2% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 14 | 11,749 | $467,212 | $139,704 | 29.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 52 | 4,560 | $245,340 | $78,463 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 436 | 711 | $202,635 | $66,099 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 157 | 255 | $102,000 | $34,616 | 33.9% |
About Dr. Lori Siegel, MD
Dr. Lori Siegel, MD is a Rheumatology healthcare provider based in Bannockburn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730144882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lori Siegel, MD has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $272,942 received in 2024. These payments were reported across 3,022 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.2M).
As a Medicare-enrolled provider, Siegel has provided services to 10,871 Medicare beneficiaries, totaling 102,145 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Bannockburn, IL
- Active Since 04/20/2006
- Last Updated 11/26/2012
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1730144882
Products in Payments
- EVENITY (Biological) $321,259
- Prolia (Biological) $224,996
- RINVOQ (Biological) $139,779
- Cimzia (Drug) $124,200
- BENLYSTA (Biological) $97,523
- COSENTYX (Biological) $86,655
- SKYRIZI (Biological) $82,648
- KEVZARA (Drug) $72,854
- RINVOQ (Drug) $34,572
- Humira (Biological) $28,949
- Rinvoq (Biological) $28,817
- Bimzelx (Biological) $23,827
- OFEV (Drug) $17,732
- KEVZARA (Biological) $7,749
- XELJANZ (Drug) $3,160
- HUMIRA (Biological) $2,807
- KEVZARA SARILUMAB INJECTION (Biological) $945.00
- Enbrel (Biological) $864.00
- SIMPONI ARIA (Biological) $592.21
- TALTZ (Drug) $443.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.